Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Diabetes

  Free Subscription


Articles published in Acta Ophthalmol

Retrieve available abstracts of 127 articles:
HTML format



Single Articles


    July 2021
  1. FRUDD K, Sivaprasad S, Raman R, Krishnakumar S, et al
    Diagnostic circulating biomarkers to detect vision-threatening diabetic retinopathy: Potential screening tool of the future?
    Acta Ophthalmol. 2021 Jul 16. doi: 10.1111/aos.14954.
    PubMed     Abstract available


  2. HU Z, Cao X, Chen L, Su Y, et al
    Monitoring intraocular proangiogenic and profibrotic cytokines within 7 days after adjunctive anti-vascular endothelial growth factor therapy for proliferative diabetic retinopathy.
    Acta Ophthalmol. 2021 Jul 14. doi: 10.1111/aos.14957.
    PubMed     Abstract available


    June 2021
  3. SCANLON PH, Nevill CR, Stratton IM, Maruti SS, et al
    Prevalence and incidence of diabetic retinopathy (DR) in the UK population of Gloucestershire.
    Acta Ophthalmol. 2021 Jun 28. doi: 10.1111/aos.14927.
    PubMed     Abstract available


  4. FEDOTKINA O, Luk A, Jain R, Prasad RB, et al
    Perinatal famine is associated with excess risk of proliferative retinopathy in patients with type 2 diabetes.
    Acta Ophthalmol. 2021 Jun 24. doi: 10.1111/aos.14948.
    PubMed     Abstract available


  5. ANGERMANN R, Hofer M, Huber AL, Rauchegger T, et al
    The impact of compliance among patients with diabetic macular oedema treated with intravitreal aflibercept: a 48-month follow-up study.
    Acta Ophthalmol. 2021 Jun 17. doi: 10.1111/aos.14946.
    PubMed     Abstract available


  6. MENG J, Han X, Wang W, Gong X, et al
    Analysis of Iris volume using swept-source optical coherence tomography in patients with type 2 diabetes mellitus.
    Acta Ophthalmol. 2021 Jun 16. doi: 10.1111/aos.14931.
    PubMed     Abstract available


  7. LANG GE, Stahl A, Voegeler J, Quiering C, et al
    Observational outcomes in proliferative diabetic retinopathy patients following treatment with ranibizumab, panretinal laser photocoagulation or combination therapy - The non-interventional second year follow-up to the PRIDE study.
    Acta Ophthalmol. 2021 Jun 14. doi: 10.1111/aos.14907.
    PubMed     Abstract available


  8. THAGAARD MS, Vergmann AS, Grauslund J
    Topical treatment of diabetic retinopathy: a systematic review.
    Acta Ophthalmol. 2021 Jun 6. doi: 10.1111/aos.14912.
    PubMed     Abstract available


    May 2021
  9. RIDDERSKAR L, Montan P, Kugelberg M, Nilsson I, et al
    Outcome of cataract surgery in eyes with diabetic retinopathy: a Swedish national cataract register report.
    Acta Ophthalmol. 2021 May 27. doi: 10.1111/aos.14914.
    PubMed     Abstract available


  10. LINDBOE JB, Schmidt Laugesen C, Sorensen TL, Brynskov T, et al
    Similar real-world two-year visual acuity gains in treatment-naive patients with diabetic macular oedema treated with a loading dose of three initial monthly injections versus less intensive regimens of intravitreal anti-vascular endothelial growth fa
    Acta Ophthalmol. 2021 May 6. doi: 10.1111/aos.14724.
    PubMed    


  11. LIN Q, Jia Y, Li T, Wang S, et al
    Optic disc morphology and peripapillary atrophic changes in diabetic children and adults without diabetic retinopathy or visual impairment.
    Acta Ophthalmol. 2021 May 5. doi: 10.1111/aos.14885.
    PubMed     Abstract available


  12. MINAKER SA, Mason RH, Lahaie Luna G, Farahvash A, et al
    Changes in aqueous and vitreous inflammatory cytokine levels in diabetic macular oedema: a systematic review and meta-analysis.
    Acta Ophthalmol. 2021 May 4. doi: 10.1111/aos.14891.
    PubMed     Abstract available


    March 2021
  13. COHEN ADN, Mimouni M, El-Yaniv R, Blumenthal EZ, et al
    Shortening the Early Treatment Diabetic Retinopathy Study visual acuity test utilizing a novel computer software: reproducibility in control and patient eyes.
    Acta Ophthalmol. 2021 Mar 19. doi: 10.1111/aos.14807.
    PubMed     Abstract available


  14. MLCAK P, Chlup R, Kudlova P, Krystynik O, et al
    Retinal oxygen saturation is associated with HbA1c but not with short-term diabetes control, internal environment, smoking and mild retinopathy - ROXINEGLYD study.
    Acta Ophthalmol. 2021 Mar 19. doi: 10.1111/aos.14853.
    PubMed     Abstract available


  15. KUBIN AM, Wirkkala J, Keskitalo A, Ohtonen P, et al
    Handheld fundus camera performance, image quality and outcomes of diabetic retinopathy grading in a pilot screening study.
    Acta Ophthalmol. 2021 Mar 16. doi: 10.1111/aos.14850.
    PubMed     Abstract available


    February 2021
  16. MANKOC RAMUS S, Pungersek G, Petrovic MG, Petrovic D, et al
    The GG genotype of erythropoietin rs1617640 polymorphism affects the risk of proliferative diabetic retinopathy in Slovenian subjects with type 2 diabetes mellitus: enemy or ally?
    Acta Ophthalmol. 2021 Feb 17. doi: 10.1111/aos.14813.
    PubMed     Abstract available


  17. KARASON KT, Vo D, Grauslund J, Rasmussen ML, et al
    Comparison of different methods of retinal imaging for the screening of diabetic retinopathy: a systematic review.
    Acta Ophthalmol. 2021 Feb 2. doi: 10.1111/aos.14767.
    PubMed     Abstract available


    January 2021
  18. BONTZOS G, Kabanarou SA, Gkizis I, Ragkousis A, et al
    Retinal neurodegeneration, macular circulation and morphology of the foveal avascular zone in diabetic patients: quantitative cross-sectional study using OCT-A.
    Acta Ophthalmol. 2021 Jan 10. doi: 10.1111/aos.14754.
    PubMed     Abstract available


  19. PESONEN M, Kankaanpaa E, Vottonen P
    Cost-effectiveness of dexamethasone and triamcinolone for the treatment of diabetic macular oedema in Finland: A Markov-model.
    Acta Ophthalmol. 2021 Jan 9. doi: 10.1111/aos.14745.
    PubMed     Abstract available


  20. WEISNER G, Blindbaek SL, Tang FY, Cheung CY, et al
    Non-invasive structural and metabolic retinal markers of disease activity in non-proliferative diabetic retinopathy.
    Acta Ophthalmol. 2021 Jan 8. doi: 10.1111/aos.14761.
    PubMed     Abstract available


    December 2020
  21. VERGMANN AS, Torp TL, Kawasaki R, Hestoy DH, et al
    Retinal vascular oxygen saturation in response to a less extensive laser treatment in proliferative diabetic retinopathy.
    Acta Ophthalmol. 2020 Dec 23. doi: 10.1111/aos.14727.
    PubMed     Abstract available


  22. WANG Q, Liu L, Jonas JB, Gao B, et al
    Albuminuria and retinal vessel density in diabetes without diabetic retinopathy: the Kailuan Eye Study.
    Acta Ophthalmol. 2020 Dec 23. doi: 10.1111/aos.14670.
    PubMed     Abstract available


  23. REGO LORCA D, Rouco Fernandez A, Jimenez Santos M, Saenz-Frances F, et al
    Bilateral retinal vein occlusion and diabetic retinopathy after COVID-19.
    Acta Ophthalmol. 2020 Dec 23. doi: 10.1111/aos.14718.
    PubMed    


  24. YAMADA Y, Takamura Y, Morioka M, Gozawa M, et al
    Microaneurysm density in residual oedema after anti-vascular endothelial growth factor therapy for diabetic macular oedema.
    Acta Ophthalmol. 2020 Dec 16. doi: 10.1111/aos.14706.
    PubMed     Abstract available


  25. FALLICO M, Maugeri A, Lotery A, Longo A, et al
    Intravitreal anti-vascular endothelial growth factors, panretinal photocoagulation and combined treatment for proliferative diabetic retinopathy: a systematic review and network meta-analysis.
    Acta Ophthalmol. 2020 Dec 16. doi: 10.1111/aos.14681.
    PubMed     Abstract available


    November 2020
  26. GABRIELLE PH, Nguyen V, Bhandari S, Mehta H, et al
    Initial observation or treatment for diabetic macular oedema with good visual acuity: two-year outcomes comparison in routine clinical practice: data from the Fight Retinal Blindness! Registry.
    Acta Ophthalmol. 2020 Nov 16. doi: 10.1111/aos.14672.
    PubMed     Abstract available


  27. WANG L DAGGER, Liu S dagger, Wang W, He M, et al
    Association between ocular biometrical parameters and diabetic retinopathy in Chinese adults with type 2 diabetes mellitus.
    Acta Ophthalmol. 2020 Nov 16. doi: 10.1111/aos.14671.
    PubMed     Abstract available


    October 2020
  28. XU Y, Wang A, Lin X, Xu J, et al
    Global burden and gender disparity of vision loss associated with diabetes retinopathy.
    Acta Ophthalmol. 2020 Oct 29. doi: 10.1111/aos.14644.
    PubMed     Abstract available


  29. MASSIGNAM ET, Dieter C, Pellenz FM, Assmann TS, et al
    Involvement of miR-126 rs4636297 and miR-146a rs2910164 polymorphisms in the susceptibility for diabetic retinopathy: a case-control study in a type 1 diabetes population.
    Acta Ophthalmol. 2020 Oct 29. doi: 10.1111/aos.14638.
    PubMed     Abstract available


    September 2020
  30. BYBERG S, Vistisen D, Jorgensen ME, Diaz LJ, et al
    Quality assessment of a screening algorithm for diabetic retinopathy: prolongation of screening intervals with minimal effect of HbA1c and arterial hypertension on the length of intervals.
    Acta Ophthalmol. 2020 Sep 15. doi: 10.1111/aos.14590.
    PubMed     Abstract available


  31. WU Z, Liu B, Ma Y, Chen H, et al
    Discovery and validation of hsa_circ_0001953 as a potential biomarker for proliferative diabetic retinopathy in human blood.
    Acta Ophthalmol. 2020 Sep 10. doi: 10.1111/aos.14585.
    PubMed     Abstract available


  32. SHAN Y, Xu Y, Lin X, Lou L, et al
    Burden of vision loss due to diabetic retinopathy in China from 1990 to 2017: findings from the global burden of disease study.
    Acta Ophthalmol. 2020 Sep 1. doi: 10.1111/aos.14573.
    PubMed     Abstract available


    August 2020
  33. LOUKOVAARA S, Haukka J
    Cancer is associated with a 2.7 higher risk for intravitreal injection therapy in patients with age-related, diabetic, or vascular occlusive macular edema.
    Acta Ophthalmol. 2020 Aug 24. doi: 10.1111/aos.14546.
    PubMed    


  34. ZHANG K, Zhang S, Yu J, Lu Y, et al
    Changes of the tear film lipid layer thickness after cataract surgery in patients with diabetes mellitus.
    Acta Ophthalmol. 2020 Aug 4. doi: 10.1111/aos.14565.
    PubMed     Abstract available


    July 2020
  35. YU HS, Hong EH, Shin YU, Koh SH, et al
    ATP-binding cassette subfamily A-1 (ABCA1) levels are increased in the aqueous humour of proliferative diabetic retinopathy patients.
    Acta Ophthalmol. 2020 Jul 23. doi: 10.1111/aos.14550.
    PubMed    


  36. SCHREUR V, Brouwers J, Van Huet RAC, Smeets S, et al
    Long-term outcomes of vitrectomy for proliferative diabetic retinopathy.
    Acta Ophthalmol. 2020 Jul 9. doi: 10.1111/aos.14482.
    PubMed     Abstract available


  37. CAMPOS A, Campos EJ, Martins J, Ambrosio AF, et al
    The value of choroidal thickness in diabetic macular oedema is contradictory.
    Acta Ophthalmol. 2020 Jul 9. doi: 10.1111/aos.14529.
    PubMed    


    June 2020
  38. FALLICO M, Avitabile T, Castellino N, Longo A, et al
    Intravitreal dexamethasone implant one month before versus concomitant with cataract surgery in patients with diabetic macular oedema: the dexcat study.
    Acta Ophthalmol. 2020 Jun 26. doi: 10.1111/aos.14516.
    PubMed     Abstract available


  39. MATHIS T, Dot C, Mauget-Faysse M, Kodjikian L, et al
    Variation of choroidal thickness in diabetic macular edema: friend or foe?
    Acta Ophthalmol. 2020 Jun 26. doi: 10.1111/aos.14530.
    PubMed    


  40. CAO J, You K, Jin K, Lou L, et al
    Prediction of response to anti-vascular endothelial growth factor treatment in diabetic macular oedema using an optical coherence tomography-based machine learning method.
    Acta Ophthalmol. 2020 Jun 22. doi: 10.1111/aos.14514.
    PubMed     Abstract available


  41. HSIEH YT, Hsieh MC
    Time-sequential correlations between diabetic kidney disease and diabetic retinopathy in type 2 diabetes - an 8-year prospective cohort study.
    Acta Ophthalmol. 2020 Jun 22. doi: 10.1111/aos.14487.
    PubMed     Abstract available


    May 2020
  42. VERGMANN AS, Grauslund J
    Changes of visual fields in treatment of proliferative diabetic retinopathy: a systematic review.
    Acta Ophthalmol. 2020 May 18. doi: 10.1111/aos.14474.
    PubMed     Abstract available


  43. C B B VEIBY N, Simeunovic A, Heier M, Brunborg C, et al
    Venular oxygen saturation is increased in young patients with type 1 diabetes and mild nonproliferative diabetic retinopathy.
    Acta Ophthalmol. 2020 May 15. doi: 10.1111/aos.14462.
    PubMed     Abstract available


    April 2020
  44. MATHIS T, Mendes M, Dot C, Bouteleux V, et al
    Increased choroidal thickness: a new indicator for monitoring diabetic macular oedema recurrence.
    Acta Ophthalmol. 2020 Apr 17. doi: 10.1111/aos.14447.
    PubMed     Abstract available


  45. GABRIELLE PH, Massin P, Arnould L, Couturier A, et al
    Development of a 1-year risk-prediction nomogram for good functional response with anti-VEGF agents in naive diabetic macular oedema.
    Acta Ophthalmol. 2020 Apr 8. doi: 10.1111/aos.14428.
    PubMed     Abstract available


  46. KIM M, Kim RY, Park W, Park YG, et al
    Electroretinography and retinal microvascular changes in type 2 diabetes.
    Acta Ophthalmol. 2020 Apr 4. doi: 10.1111/aos.14421.
    PubMed     Abstract available


    March 2020
  47. ESTIL S, Steinarsson AThorn, Einarsson S, Aspelund T, et al
    Diabetic eye screening with variable screening intervals based on individual risk factors is safe and effective in ophthalmic practice.
    Acta Ophthalmol. 2020 Mar 25. doi: 10.1111/aos.14425.
    PubMed     Abstract available


  48. BUSCH C, Okada M, Zur D, Fraser-Bell S, et al
    Baseline predictors for visual acuity loss during observation in diabetic macular oedema with good baseline visual acuity.
    Acta Ophthalmol. 2020 Mar 1. doi: 10.1111/aos.14390.
    PubMed     Abstract available


  49. BOLME S, Morken TS, Follestad T, Sorensen TL, et al
    Task shifting of intraocular injections from physicians to nurses: a randomized single-masked noninferiority study.
    Acta Ophthalmol. 2020;98:139-144.
    PubMed     Abstract available


    February 2020
  50. YAO TT, Yang Y, Jin XL, Wang YX, et al
    Intraocular pharmacokinetics of anti-vascular endothelial growth factor agents by intraoperative subretinal versus intravitreal injection in silicone oil-filled eyes of proliferative diabetic retinopathy: a randomized controlled pilot study.
    Acta Ophthalmol. 2020 Feb 29. doi: 10.1111/aos.14386.
    PubMed     Abstract available


  51. ELKJAER AS, Lynge SK, Grauslund J
    Evidence and indications for systemic treatment in diabetic retinopathy: a systematic review.
    Acta Ophthalmol. 2020 Feb 26. doi: 10.1111/aos.14377.
    PubMed     Abstract available


  52. DE CLERCK EEB, Schouten JSAG, Berendschot TTJM, Koolschijn RS, et al
    Reduced corneal nerve fibre length in prediabetes and type 2 diabetes: The Maastricht Study.
    Acta Ophthalmol. 2020 Feb 3. doi: 10.1111/aos.14359.
    PubMed     Abstract available


    January 2020
  53. BA-ALI S, Brondsted AE, Andersen HU, Jennum P, et al
    Pupillary light responses in type 1 and type 2 diabetics with and without retinopathy.
    Acta Ophthalmol. 2020 Jan 13. doi: 10.1111/aos.14348.
    PubMed     Abstract available


  54. SEVER O, Horozoglu F
    Bariatric surgery might aggravate proliferative diabetic retinopathy.
    Acta Ophthalmol. 2020 Jan 7. doi: 10.1111/aos.14342.
    PubMed     Abstract available


    December 2019
  55. EPSTEIN D, Mirabelli P, Lovestam Adrian M
    Treatment algorithm with dexamethasone intravitreal implant in patients with diabetic macular edema.
    Acta Ophthalmol. 2019 Dec 29. doi: 10.1111/aos.14339.
    PubMed    


  56. LANG GE, Stahl A, Voegeler J, Quiering C, et al
    Efficacy and safety of ranibizumab with or without panretinal laser photocoagulation versus laser photocoagulation alone in proliferative diabetic retinopathy - the PRIDE study.
    Acta Ophthalmol. 2019 Dec 6. doi: 10.1111/aos.14312.
    PubMed     Abstract available


    November 2019
  57. GONZALEZ-GONZALO C, Sanchez-Gutierrez V, Hernandez-Martinez P, Contreras I, et al
    Evaluation of a deep learning system for the joint automated detection of diabetic retinopathy and age-related macular degeneration.
    Acta Ophthalmol. 2019 Nov 26. doi: 10.1111/aos.14306.
    PubMed     Abstract available


  58. BRITO P, Costa J, Gomes N, Costa S, et al
    Serum pro-inflammatory factors as predictors of persistent diabetic macular oedema with limited anatomic response to anti-VEGF: association with intravitreal injection treatment profiles in real-world setting.
    Acta Ophthalmol. 2019 Nov 19. doi: 10.1111/aos.14308.
    PubMed     Abstract available


  59. PODKOWINSKI D, Orlowski-Wimmer E, Zlabinger G, Pollreisz A, et al
    Aqueous humour cytokine changes during a loading phase of intravitreal ranibizumab or dexamethasone implant in diabetic macular oedema.
    Acta Ophthalmol. 2019 Nov 17. doi: 10.1111/aos.14297.
    PubMed     Abstract available


  60. BOLZ M, Podkowinski D, Pretzl J, Mursch-Edlmayr AS, et al
    Patterns of morphologic alteration correlate with vision in diabetic macular oedema: a cross-sectional evaluation of patients using the SAVE II protocol.
    Acta Ophthalmol. 2019 Nov 17. doi: 10.1111/aos.14288.
    PubMed     Abstract available


  61. TAKAYAMA K, Someya H, Yokoyama H, Kimura T, et al
    Prognostic factors of revitrectomy for complications in eyes with proliferative diabetic retinopathy: a retrospective multicentre study.
    Acta Ophthalmol. 2019 Nov 1. doi: 10.1111/aos.14292.
    PubMed     Abstract available


  62. PETRARCA R, Soare C, Wong R, Desai R, et al
    Intravitreal ranibizumab for persistent diabetic vitreous haemorrhage: a randomised, double-masked, placebo-controlled feasibility study.
    Acta Ophthalmol. 2019 Nov 1. doi: 10.1111/aos.14282.
    PubMed     Abstract available


    October 2019
  63. TIAN M, Wolf S, Munk MR, Schaal KB, et al
    Evaluation of different Swept'Source optical coherence tomography angiography (SS-OCTA) slabs for the detection of features of diabetic retinopathy.
    Acta Ophthalmol. 2019 Oct 30. doi: 10.1111/aos.14299.
    PubMed     Abstract available


  64. GRANSTAM E, Rosenblad A, Modher Raghib A, Granstrom T, et al
    Long-term follow-up of antivascular endothelial growth factor treatment for diabetic macular oedema: a four-year real-world study.
    Acta Ophthalmol. 2019 Oct 27. doi: 10.1111/aos.14290.
    PubMed     Abstract available


  65. BLINDBAEK SL, Peto T, Grauslund J
    Alterations in retinal arteriolar microvascular structure associate with higher treatment burden in patients with diabetic macular oedema: results from a 12-month prospective clinical trial.
    Acta Ophthalmol. 2019 Oct 25. doi: 10.1111/aos.14278.
    PubMed     Abstract available


  66. GERENDAS BS, Hatz K, Kaider A, Zulewski H, et al
    Ganglion cell layer thickening in well-controlled patients with type 1 diabetes: an early sign for diabetic retinopathy?
    Acta Ophthalmol. 2019 Oct 25. doi: 10.1111/aos.14273.
    PubMed     Abstract available


  67. MITSCH C, Pemp B, Pollreisz A, Gleiss A, et al
    Short-time effect of intravitreal injections on retinal vascular oxygenation and vessel diameter in patients with diabetic macular oedema or neovascular age-related macular degeneration.
    Acta Ophthalmol. 2019 Oct 25. doi: 10.1111/aos.14276.
    PubMed     Abstract available


  68. BLINDBAEK SL, Peto T, Grauslund J
    Aflibercept and navigated versus conventional laser in diabetic macular oedema: a 12-month randomized clinical trial.
    Acta Ophthalmol. 2019 Oct 10. doi: 10.1111/aos.14266.
    PubMed     Abstract available


    September 2019
  69. MCANANY JJ, Park JC, Liu K, Liu M, et al
    Contrast sensitivity is associated with outer-retina thickness in early-stage diabetic retinopathy.
    Acta Ophthalmol. 2019 Sep 13. doi: 10.1111/aos.14241.
    PubMed     Abstract available


  70. VERBRAAK FD, Schmidt-Erfurth U, Grzybowski A, Abramoff M, et al
    Is automated screening for diabetic retinopathy indeed not yet ready as stated by Grauslund et al.?
    Acta Ophthalmol. 2019 Sep 1. doi: 10.1111/aos.14236.
    PubMed    


    August 2019
  71. MUNUERA-GIFRE E, Saez M, Juvinya-Canals D, Rodriguez-Poncelas A, et al
    Analysis of the location of retinal lesions in central retinographies of patients with Type 2 diabetes.
    Acta Ophthalmol. 2019 Aug 30. doi: 10.1111/aos.14223.
    PubMed     Abstract available


  72. ZUR D, Iglicki M, Sala-Puigdollers A, Chhablani J, et al
    Disorganization of retinal inner layers as a biomarker in patients with diabetic macular oedema treated with dexamethasone implant.
    Acta Ophthalmol. 2019 Aug 17. doi: 10.1111/aos.14230.
    PubMed     Abstract available


  73. SHEN Y, Cao H, Chen F, Suo Y, et al
    A cross-sectional study of vitreous and serum high mobility group box-1 levels in proliferative diabetic retinopathy.
    Acta Ophthalmol. 2019 Aug 17. doi: 10.1111/aos.14228.
    PubMed     Abstract available


  74. LI T, Jia Y, Wang S, Xu Y, et al
    Change in peripapillary and macular choroidal thickness change in children with type 1 diabetes mellitus without visual impairment or diabetic retinopathy.
    Acta Ophthalmol. 2019 Aug 17. doi: 10.1111/aos.14225.
    PubMed     Abstract available


    July 2019
  75. ABU EL-ASRAR AM, Ahmad A, Allegaert E, Siddiquei MM, et al
    Galectin-1 studies in proliferative diabetic retinopathy.
    Acta Ophthalmol. 2019 Jul 18. doi: 10.1111/aos.14191.
    PubMed     Abstract available


  76. NGHIEM AZ, Nderitu P, Lukic M, Khatun M, et al
    Comparing diabetic retinopathy lesions in scanning laser ophthalmoscopy and colour fundus photography.
    Acta Ophthalmol. 2019 Jul 8. doi: 10.1111/aos.14106.
    PubMed     Abstract available


    June 2019
  77. KARST SG, Schuster M, Mitsch C, Meyer EL, et al
    Atrophy of the central neuroretina in patients treated for diabetic macular edema.
    Acta Ophthalmol. 2019 Jun 22. doi: 10.1111/aos.14173.
    PubMed     Abstract available


  78. NISHIDA K, Miura K, Sakaguchi H, Kamei M, et al
    The impact of spot size, spacing, pattern, duration and intensity of burns on the photocoagulation index in a geometric simulation of pan-retinal laser photocoagulation.
    Acta Ophthalmol. 2019;97:e551-e558.
    PubMed     Abstract available


    May 2019
  79. TAKASAGO Y, Fujita T, Nakano Y, Osaka R, et al
    Ranibizumab treatment improves diabetic macular oedema without influencing retinal oximetry parameters.
    Acta Ophthalmol. 2019 May 24. doi: 10.1111/aos.14145.
    PubMed     Abstract available


  80. CEKLIC L, Huf W, Ebneter A, Wolf S, et al
    The impact of ganglion cell layer cysts in diabetic macular oedema treated with anti-vascular endothelial growth factor.
    Acta Ophthalmol. 2019 May 17. doi: 10.1111/aos.14137.
    PubMed     Abstract available


  81. GRZYBOWSKI A, Brona P
    A pilot study of autonomous artificial intelligence-based diabetic retinopathy screening in Poland.
    Acta Ophthalmol. 2019 May 3. doi: 10.1111/aos.14132.
    PubMed    


    April 2019
  82. BYBERG S, Vistisen D, Diaz L, Charles MH, et al
    Optos wide-field imaging versus conventional camera imaging in Danish patients with type 2 diabetes.
    Acta Ophthalmol. 2019 Apr 15. doi: 10.1111/aos.14118.
    PubMed     Abstract available


  83. OMARI A, Niziol LM, Gardner TW
    Reading deficits in diabetic patients treated with panretinal photocoagulation and good visual acuity.
    Acta Ophthalmol. 2019 Apr 9. doi: 10.1111/aos.14097.
    PubMed     Abstract available


    March 2019
  84. SUN Z, Liu X, Bian C, Wu S, et al
    Sub-Tenon depository triamcinolone and glycaemic management in diabetic patients.
    Acta Ophthalmol. 2019 Mar 22. doi: 10.1111/aos.14100.
    PubMed    


  85. WANG J, Gao X, Liu J, Wang J, et al
    Effect of intravitreal conbercept treatment on the expression of Long Noncoding RNAs and mRNAs in Proliferative Diabetic Retinopathy Patients.
    Acta Ophthalmol. 2019 Mar 22. doi: 10.1111/aos.14083.
    PubMed     Abstract available


    February 2019
  86. LI L, Almansoob S, Zhang P, Zhou YD, et al
    Quantitative analysis of retinal and choroid capillary ischaemia using optical coherence tomography angiography in type 2 diabetes.
    Acta Ophthalmol. 2019 Feb 27. doi: 10.1111/aos.14076.
    PubMed     Abstract available


  87. COMET A, Gascon P, Sauvan L, Donnadieu B, et al
    INVICTUS: intravitreal anti-VEGF and dexamethasone implant comparison for the treatment of diabetic macular edema: a 6 months follow-up Study.
    Acta Ophthalmol. 2019 Feb 11. doi: 10.1111/aos.14057.
    PubMed    


    January 2019
  88. TAYYARI F, Khuu LA, Sivak JM, Flanagan JG, et al
    Retinal blood oxygen saturation and aqueous humour biomarkers in early diabetic retinopathy.
    Acta Ophthalmol. 2019 Jan 28. doi: 10.1111/aos.14016.
    PubMed     Abstract available


  89. KAIZU Y, Nakao S, Arima M, Wada I, et al
    Capillary dropout is dominant in deep capillary plexus in early diabetic retinopathy in optical coherence tomography angiography.
    Acta Ophthalmol. 2019 Jan 28. doi: 10.1111/aos.14041.
    PubMed    


  90. MOREN A, Sundbom M, Ottosson J, Granstam E, et al
    Response: Debate continues. Gastric bypass surgery does not increase the risk for sight-threatening diabetic retinopathy.
    Acta Ophthalmol. 2019 Jan 11. doi: 10.1111/aos.14022.
    PubMed    


  91. DANNI R, Viljanen A, Aaronson A, Tuuminen R, et al
    Preoperative anti-inflammatory treatment of diabetic patients does not improve recovery from cataract surgery when postoperatively treated with a combination of prednisolone acetate and nepafenac.
    Acta Ophthalmol. 2019 Jan 8. doi: 10.1111/aos.14018.
    PubMed     Abstract available


    December 2018
  92. BLINDBAEK SL, Peto T, Grauslund J
    How do we evaluate the role of focal/grid photocoagulation in the treatment of diabetic macular edema?
    Acta Ophthalmol. 2018 Dec 21. doi: 10.1111/aos.13997.
    PubMed     Abstract available


  93. GABRIELLE PH, Massin P, Kodjikian L, Erginay A, et al
    Central retinal thickness following panretinal photocoagulation using a multispot semi-automated pattern-scanning laser to treat ischaemic diabetic retinopathy: Treatment in one session compared with four monthly sessions.
    Acta Ophthalmol. 2018 Dec 18. doi: 10.1111/aos.14002.
    PubMed     Abstract available


  94. SEVER O
    Debate continues: Gastric bypass surgery does not increase the risk for sight-threatening diabetic retinopathy.
    Acta Ophthalmol. 2018 Dec 3. doi: 10.1111/aos.13990.
    PubMed    


    November 2018
  95. SAHIN M, Sahin A, Turkcu FM
    The relationship between retinal thickness and neurodegeneration in early diabetic patients.
    Acta Ophthalmol. 2018 Nov 18. doi: 10.1111/aos.13977.
    PubMed    


  96. DIETZEL A, Schanner C, Falck A, Hautala N, et al
    Automatic detection of diabetic retinopathy and its progression in sequential fundus images of patients with diabetes.
    Acta Ophthalmol. 2018 Nov 18. doi: 10.1111/aos.13976.
    PubMed    


    October 2018
  97. HIGHAM AK, Tahir MI, Gala K, Verroiopoulos G, et al
    Are the real-life outcomes of using aflibercept in diabetic macular oedema comparable to the landmark studies?
    Acta Ophthalmol. 2018 Oct 27. doi: 10.1111/aos.13945.
    PubMed    


  98. BONFIGLIO V, Reibaldi M, Pizzo A, Russo A, et al
    Dexamethasone for unresponsive diabetic macular oedema: optical coherence tomography biomarkers.
    Acta Ophthalmol. 2018 Oct 14. doi: 10.1111/aos.13935.
    PubMed     Abstract available


  99. HAFNER J, Karst S, Sacu S, Scholda C, et al
    Correlation between corneal and retinal neurodegenerative changes and their association with microvascular perfusion in type II diabetes.
    Acta Ophthalmol. 2018 Oct 11. doi: 10.1111/aos.13938.
    PubMed     Abstract available


  100. GRAUSLUND J, Andersen N, Andresen J, Flesner P, et al
    Evidence-based Danish guidelines for screening of diabetic retinopathy.
    Acta Ophthalmol. 2018 Oct 11. doi: 10.1111/aos.13936.
    PubMed     Abstract available


  101. POSCH-PERTL L, Michelitsch M, Schwetz V, Gasser-Steiner V, et al
    Change in choroidal volume after dexamethasone intravitreal implant in eyes with diabetic macular oedema.
    Acta Ophthalmol. 2018 Oct 3. doi: 10.1111/aos.13905.
    PubMed    


    September 2018
  102. SCHRODER K, Szendroedi J, Benthin A, Gontscharuk V, et al
    German Diabetes Study - Baseline data of retinal layer thickness measured by SD-OCT in early diabetes mellitus.
    Acta Ophthalmol. 2018 Sep 21. doi: 10.1111/aos.13851.
    PubMed     Abstract available


  103. JOHANNESEN SK, Viken JN, Vergmann AS, Grauslund J, et al
    Optical coherence tomography angiography and microvascular changes in diabetic retinopathy: a systematic review.
    Acta Ophthalmol. 2018 Sep 20. doi: 10.1111/aos.13859.
    PubMed     Abstract available


  104. MENG W, Shah KP, Pollack S, Toppila I, et al
    A genome-wide association study suggests new evidence for an association of the NADPH Oxidase 4 (NOX4) gene with severe diabetic retinopathy in type 2 diabetes.
    Acta Ophthalmol. 2018 Sep 4. doi: 10.1111/aos.13769.
    PubMed     Abstract available


    August 2018
  105. SCHREUR V, van Asten F, Ng H, Weeda J, et al
    Risk factors for development and progression of diabetic retinopathy in Dutch patients with type 1 diabetes mellitus.
    Acta Ophthalmol. 2018;96:459-464.
    PubMed     Abstract available


    June 2018
  106. RIM TH, Lee SY, Bae HW, Seong GJ, et al
    Increased risk of open-angle glaucoma among patients with diabetes mellitus: a 10-year follow-up nationwide cohort study.
    Acta Ophthalmol. 2018 Jun 4. doi: 10.1111/aos.13805.
    PubMed     Abstract available


  107. REZKALLAH A, Malcles A, Dot C, Voirin N, et al
    Evaluation of efficacy and safety of dexamethasone intravitreal implants before and after vitrectomy in a real-life study.
    Acta Ophthalmol. 2018;96:e544-e546.
    PubMed    


    April 2018
  108. STEFANICKOVA J, Cunha-Vaz J, Ulbig M, Pearce I, et al
    A noninterventional study to monitor patients with diabetic macular oedema starting treatment with ranibizumab (POLARIS).
    Acta Ophthalmol. 2018 Apr 25. doi: 10.1111/aos.13771.
    PubMed     Abstract available


  109. JAKOBSEN NS, Larsen DA, Bek T
    The area of fixation covaries with short-term changes in visual acuity after anti-vascular endothelial growth factor treatment in patients with diabetic macular oedema.
    Acta Ophthalmol. 2018 Apr 24. doi: 10.1111/aos.13773.
    PubMed     Abstract available


  110. BROADGATE S, Kiire C, Halford S, Chong V, et al
    Diabetic macular oedema: under-represented in the genetic analysis of diabetic retinopathy.
    Acta Ophthalmol. 2018;96 Suppl A111:1-51.
    PubMed     Abstract available


    March 2018
  111. DE MELO LGN, Morales PH, Drummond KRG, Santos DC, et al
    Prevalence and risk factors for referable diabetic retinopathy in patients with type 1 diabetes: a nationwide study in Brazil.
    Acta Ophthalmol. 2018 Mar 14. doi: 10.1111/aos.13760.
    PubMed    


  112. PEMP B, Palkovits S, Howorka K, Pumprla J, et al
    Correlation of retinal neurodegeneration with measures of peripheral autonomic neuropathy in type 1 diabetes.
    Acta Ophthalmol. 2018 Mar 5. doi: 10.1111/aos.13733.
    PubMed     Abstract available


    February 2018
  113. LIU TT, Hao Q, Zhang Y, Li ZH, et al
    Effects of microRNA-133b on retinal vascular endothelial cell proliferation and apoptosis through angiotensinogen-mediated angiotensin II- extracellular signal-regulated kinase 1/2 signalling pathway in rats with diabetic retinopathy.
    Acta Ophthalmol. 2018 Feb 28. doi: 10.1111/aos.13715.
    PubMed     Abstract available


    January 2018
  114. JANSSON RW, Hufthammer KO, Krohn J
    Diabetic retinopathy in type 1 diabetes patients in Western Norway.
    Acta Ophthalmol. 2018 Jan 25. doi: 10.1111/aos.13654.
    PubMed     Abstract available


    December 2017
  115. HODZIC-HADZIBEGOVIC D, Sander BA, Monberg TJ, Larsen M, et al
    Diabetic macular oedema treated with intravitreal anti-vascular endothelial growth factor - 2-4 years follow-up of visual acuity and retinal thickness in 566 patients following Danish national guidelines.
    Acta Ophthalmol. 2017 Dec 14. doi: 10.1111/aos.13638.
    PubMed     Abstract available


  116. FOGLIA E, Ferrario L, Bandello F, Ferri C, et al
    Diabetic macular edema, innovative technologies and economic impact: New opportunities for the Lombardy Region healthcare system?
    Acta Ophthalmol. 2017 Dec 14. doi: 10.1111/aos.13620.
    PubMed     Abstract available


  117. POSCH-PERTL L, Schwetz V, Michelitsch M, Rabensteiner J, et al
    Effect of dexamethasone intravitreal implant on blood glucose, hypothalamic-pituitary-adrenal axis function and vascular endothelial growth factor serum levels in patients with diabetic macular oedema.
    Acta Ophthalmol. 2017 Dec 8. doi: 10.1111/aos.13615.
    PubMed    


  118. GRAUSLUND J
    Vascular endothelial growth factor inhibition for proliferative diabetic retinopathy: Et tu, Brute?
    Acta Ophthalmol. 2017;95:757-758.
    PubMed    


    November 2017
  119. TORP TL, Kawasaki R, Wong TY, Peto T, et al
    Temporal changes in retinal vascular parameters associated with successful panretinal photocoagulation in proliferative diabetic retinopathy: A prospective clinical interventional study.
    Acta Ophthalmol. 2017 Nov 29. doi: 10.1111/aos.13617.
    PubMed     Abstract available


  120. VAN DER HEIJDEN AA, Abramoff MD, Verbraak F, van Hecke MV, et al
    Validation of automated screening for referable diabetic retinopathy with the IDx-DR device in the Hoorn Diabetes Care System.
    Acta Ophthalmol. 2017 Nov 27. doi: 10.1111/aos.13613.
    PubMed     Abstract available


  121. CHEN C, Chen X, Huang H, Han C, et al
    Elevated plasma and vitreous levels of leucine-rich-alpha2-glycoprotein are associated with diabetic retinopathy progression.
    Acta Ophthalmol. 2017 Nov 23. doi: 10.1111/aos.13633.
    PubMed     Abstract available


  122. ABU EL-ASRAR AM, Ahmad A, Alam K, Bittoun E, et al
    Association of 150-kDa oxygen-regulated protein with vascular endothelial growth factor in proliferative diabetic retinopathy.
    Acta Ophthalmol. 2017 Nov 2. doi: 10.1111/aos.13600.
    PubMed     Abstract available


  123. DE CLERCK EEB, Schouten JSAG, Berendschot TTJM, Goezinne F, et al
    Macular thinning in prediabetes or type 2 diabetes without diabetic retinopathy: the Maastricht Study.
    Acta Ophthalmol. 2017 Nov 1. doi: 10.1111/aos.13570.
    PubMed     Abstract available


  124. LANG GE, Liakopoulos S, Vogeler J, Weiss C, et al
    The RELATION study: efficacy and safety of ranibizumab combined with laser photocoagulation treatment versus laser monotherapy in NPDR and PDR patients with diabetic macular oedema.
    Acta Ophthalmol. 2017 Nov 1. doi: 10.1111/aos.13574.
    PubMed     Abstract available


    October 2017
  125. PRAGER SG, Lammer J, Mitsch C, Hafner J, et al
    Analysis of retinal layer thickness in diabetic macular oedema treated with ranibizumab or triamcinolone.
    Acta Ophthalmol. 2017 Oct 24. doi: 10.1111/aos.13520.
    PubMed     Abstract available


    September 2017
  126. WANG K, Jayadev C, Nittala MG, Velaga SB, et al
    Automated detection of diabetic retinopathy lesions on ultrawidefield pseudocolour images.
    Acta Ophthalmol. 2017 Sep 19. doi: 10.1111/aos.13528.
    PubMed     Abstract available


  127. SCARINCI F, Picconi F, Giorno P, Boccassini B, et al
    Deep capillary plexus impairment in patients with type 1 diabetes mellitus with no signs of diabetic retinopathy revealed using optical coherence tomography angiography.
    Acta Ophthalmol. 2017 Sep 9. doi: 10.1111/aos.13510.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: